|Drug conjugates—an emerging approach to treat breast cancer|
M Hasan, RK Leak, RE Stratford, DP Zlotos, PA Witt‐Enderby
Pharmacology research & perspectives 6 (4), e00417, 2018
|Oxyprenylated phenylpropanoids bind to MT1 melatonin receptors and inhibit breast cancer cell proliferation and migration|
M Hasan, S Genovese, S Fiorito, F Epifano, PA Witt-Enderby
Journal of natural products 80 (12), 3324-3329, 2017
|Pharmacological, mechanistic, and pharmacokinetic assessment of novel melatonin-tamoxifen drug conjugates as breast cancer drugs|
M Hasan, MA Marzouk, S Adhikari, TD Wright, BP Miller, MD Matossian, ...
Molecular pharmacology 96 (2), 272-296, 2019
|Co-administering melatonin with an estradiol-progesterone menopausal hormone therapy represses mammary cancer development in a mouse model of HER2-positive breast cancer|
BR Dodda, CD Bondi, M Hasan, WP Clafshenkel, KM Gallagher, ...
Frontiers in oncology 9, 525, 2019
|Assessment of the antioxidant, thrombolytic, analgesic, anti-inflammatory, antidepressant and anxiolytic activities of leaf extracts and fractions of Tetracera sarmentosa (L.) Vahl|
MMN Uddin, MSH Kabir, M Hasan, Z Al Mahmud, NMMA Bhuiya, ...
Journal of basic and clinical physiology and pharmacology 29 (1), 81-93, 2018
|In vivo analgesic, antipyretic and anti-inflammatory potential of leaf extracts and fractions of Eria javanica|
NMMA Bhuiya, M Hasan, Z Al Mahmud, N Qais, MSH Kabir, F Ahmed, ...
Journal of Complementary and Integrative Medicine 14 (1), 2017
|Novel melatonin, estrogen, and progesterone hormone therapy demonstrates anti-cancer actions in MCF-7 and MDA-MB-231 breast cancer cells|
M Hasan, E Browne, L Guarinoni, T Darveau, K Hilton, PA Witt-Enderby
Breast Cancer: Basic and Clinical Research 14, 1178223420924634, 2020
|Melatonin-tamoxifen hybrid ligands and their effects on breast cancer|
M Hasan, MA Marzouk, S Adhikari, T Wright, B Miller, B Peckich, ...
Cancer Research 78 (13 Supplement), 3915-3915, 2018
|Prevalence of Covid-19 Associated Symptoms, Their Onset and Duration, and Variations Among Different Groups of Patients in Bangladesh|
M Amin, M Hasan, NM Bhuiya
Frontiers in Public Health, 1417, 2021
|Dual inhibition of the PI3k/Akt and MEK5/ERK5 pathways in tamoxifen resistant breast cancer|
TD Wright, M Hasan, P Witt-Enderby, J Cavanaugh
Cancer Research 77 (13 Supplement), 2365-2365, 2017